IP Library Granted Patent US 10,081,818
Granted Patent B2
US 10,081,818 · App. 15/430,122 · Granted Sep 25, 2018

Chemical engineering processes and apparatus for the synthesis of compounds

Inventors: Richard Peet (Washington, DC); Malcolm J. Kavarana (Fairfax, VA); Robert Winnicki (Cambridge, MA); Marc Donsky (Denver, CO); Mingyang Sun (Dublin, IE)
Assignee: TEEWINOT TECHNOLOGIES LIMITED
C12P7/26A01H6/28C12N9/0004C12N9/1029C12P7/22C12Y121/03007C12Y121/03008C12Y203/01206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,081,818
App. No.
15/430,122
Granted
Sep 25, 2018
Kind
B2
Abstract

The present invention provides methods for producing cannabinoids and cannabinoid analogs as well as a system for producing these compounds. The inventive method is directed to contacting a compound according to Formula I or Formula II with a cannabinoid synthase. Also described is a system for producing cannabinoids and cannabinoid analogs by contacting a THCA synthase with a cannabinoid precursor and modifying at least one property of the reaction mixture to influence the quantity formed of a first cannabinoid relative to the quantity formed of a second cannabinoid.

Claims (24)

1. A method of producing one or more cannabinoids comprising:

reacting a compound according to Formula I:

with a recombinant cannabinoid synthase as a catalyst in a reaction mixture;

controlling a property of the reaction mixture to modify the amount of the one or more cannabinoids which are catalyzed by the recombinant cannabinoid synthase;

wherein

R 1 is H or —COOH;

R 2 is selected from the group consisting of linear or branched CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 6 H 13 , C 7 H 15 and C 8 H 17 ; and

wherein the cannabinoid synthase is selected from the group consisting of a cannabidiolic acid synthase and a tetrahydrocannabinolic acid synthase;

wherein the reaction mixture comprises dimethyl sulfoxide (DMSO), and wherein the amount of the DMSO in the reaction mixture is between 5% and 30% (v/v).

2. The method of claim 1 , wherein R 2 is selected from the group consisting of linear CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 6 H 13 , C 7 H 15 and C 8 H 17 .

3. The method of claim 2 , wherein R 2 is a linear C 3 H 7 group.

4. The method of claim 1 , further comprising conjugating the recombinant cannabinoid synthase to a solid support.

5. The method of claim 1 , wherein the cannabinoid is a single enantiomer.

6. The method of claim 1 , wherein the enantiomeric purity of the cannabinoid is at least 95%.

7. The method of claim 6 , wherein the enantiomeric purity of the cannabinoid is at least 99%.

8. The method of claim 1 , wherein the recombinant cannabinoid synthase is a recombinant tetrahydrocannabinolic acid synthase (THCA synthase).

9. The method of claim 1 , wherein the recombinant cannabinoid synthase is overexpressed in a host cell.

10. The method of claim 9 , wherein the recombinant cannabinoid synthase is THCA synthase.

11. The method of claim 10 , wherein the THCA synthase is overexpressed in yeast or in Escherichia coli.

12. The method of claim 1 , wherein the recombinant cannabinoid synthase is cannabidiolic acid (CBDA) synthase.

13. The method of claim 1 , further comprising isolating the cannabinoid.

14. The method of claim 1 , further comprising decarboxylating the cannabinoid.

15. The method of claim 1 , wherein the property is pH of the reaction mixture.

16. The method of claim 15 , wherein the pH of the reaction mixture is between 4.0 and 8.0.

Assignments (8)
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0448 →
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0474 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058180/0377 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058182/0033 →
SECURITY INTEREST Recorded Aug 24, 2020
From: TEEWINOT TECHNOLOGIES, LTD.
To: TUATARA CAPITAL FUND I, L.P.
Reel/Frame 053582/0897 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2018
From: KAVARANA, MALCOLM J.
To: TEEWINOT TECHNOLOGIES LIMITED
Reel/Frame 046484/0088 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2018
From: WINNICKI, ROBERT; DONSKY, MARC
To: FULL SPECTRUM LABORATORIES LIMITED
Reel/Frame 046194/0254 →
CHANGE OF NAME Recorded Dec 8, 2017
From: FULL SPECTRUM LABORATORIES LIMITED
To: TEEWINOT TECHNOLOGIES LIMITED
Reel/Frame 044804/0125 →
Continuity (6)
Continuation 15242189 · Aug 19, 2016
Continuation 15171517 · Jun 2, 2016
Continuation 14836339 · Aug 26, 2015
Continuation PCTUS2014018944 · Feb 27, 2014
Provisional Application 61770766 · Feb 28, 2013
Related Publication 20170152530A1 · Jun 1, 2017
Cited By (1)
US 12,480,144